PURPOSE: Lymphatic spread of tumor is an important prognostic factor for patients with non-small cell lung carcinoma (NSCLC). Vascular endothelial growth factor-C (VEGF-C) and VEGF-D play important roles in lymphangiogenesis via the VEGF receptor 3 (VEGFR-3). We sought to determine whether VEGF-C, VEGF-D and VEGFR-3 are involved in the clinical outcomes of patients with resected NSCLC. MATERIALS AND METHODS: Using immunohistochemical staining, we investigated the protein expressions of VEGF-C, VEGF-D and VEGFR-3 in the tissue array specimens from patients who underwent resection for NSCLC. The immunoreactivity for p53 was also examined. The clinicopathological implications of these molecules were statistically analyzed. RESULTS: Analysis of a total of 118 specimens showed that VEGF-C, VEGF-D and their co-expression were significantly associated with more advanced regional lymph node metastasis (p=0.019, p=0.044 and p=0.026, respectively, N2 versus N0 and N1). A VEGFR-3 expression had a strong correlation with peritumoral lymphatic invasion (p=0.047). On the multivariate analysis for survival and recurrence, pathologic N2 lymph node metastasis was the only independent prognostic factor, but none of the investigated molecules showed any statistical correlation with recurrence and survival. CONCLUSIONS: The present study revealed that high expressions of VEGF-C and VEGF-D were strongly associated with more advanced regional lymph node metastasis in patients with resected NSCLC.
PURPOSE: Lymphatic spread of tumor is an important prognostic factor for patients with non-small cell lung carcinoma (NSCLC). Vascular endothelial growth factor-C (VEGF-C) and VEGF-D play important roles in lymphangiogenesis via the VEGF receptor 3 (VEGFR-3). We sought to determine whether VEGF-C, VEGF-D and VEGFR-3 are involved in the clinical outcomes of patients with resected NSCLC. MATERIALS AND METHODS: Using immunohistochemical staining, we investigated the protein expressions of VEGF-C, VEGF-D and VEGFR-3 in the tissue array specimens from patients who underwent resection for NSCLC. The immunoreactivity for p53 was also examined. The clinicopathological implications of these molecules were statistically analyzed. RESULTS: Analysis of a total of 118 specimens showed that VEGF-C, VEGF-D and their co-expression were significantly associated with more advanced regional lymph node metastasis (p=0.019, p=0.044 and p=0.026, respectively, N2 versus N0 and N1). A VEGFR-3 expression had a strong correlation with peritumoral lymphatic invasion (p=0.047). On the multivariate analysis for survival and recurrence, pathologic N2 lymph node metastasis was the only independent prognostic factor, but none of the investigated molecules showed any statistical correlation with recurrence and survival. CONCLUSIONS: The present study revealed that high expressions of VEGF-C and VEGF-D were strongly associated with more advanced regional lymph node metastasis in patients with resected NSCLC.
Authors: Stefan Jüttner; Christoph Wissmann; Thomas Jöns; Michael Vieth; Johannes Hertel; Stephan Gretschel; Peter M Schlag; Wolfgang Kemmner; Michael Höcker Journal: J Clin Oncol Date: 2005-12-12 Impact factor: 44.544
Authors: Jeff D White; Peter W Hewett; Dennis Kosuge; Thomas McCulloch; Berndt C Enholm; James Carmichael; J Clifford Murray Journal: Cancer Res Date: 2002-03-15 Impact factor: 12.701
Authors: E Mylona; P Alexandrou; A Mpakali; I Giannopoulou; G Liapis; S Markaki; A Keramopoulos; L Nakopoulou Journal: Eur J Surg Oncol Date: 2006-11-28 Impact factor: 4.424
Authors: Y Yokoyama; D S Charnock-Jones; D Licence; A Yanaihara; J M Hastings; C M Holland; M Emoto; M Umemoto; T Sakamoto; S Sato; H Mizunuma; S K Smith Journal: Br J Cancer Date: 2003-01-27 Impact factor: 7.640
Authors: Julia Rudno-Rudzinska; Wojciech Kielan; Zygmunt Grzebieniak; Piotr Dziegiel; Piotr Donizy; Grzegorz Mazur; Monika Knakiewicz; Ewelina Frejlich; Agnieszka Halon Journal: Gastric Cancer Date: 2012-12-14 Impact factor: 7.370
Authors: Thomas K Kilvaer; Erna-Elise Paulsen; Sigurd M Hald; Tom Wilsgaard; Roy M Bremnes; Lill-Tove Busund; Tom Donnem Journal: PLoS One Date: 2015-08-25 Impact factor: 3.240